ABSTRACT The use of high-volume quantitative radiomics features extracted from multi-parametric magnetic resonance imaging (MP-MRI) is gaining attraction for the autodetection of prostate tumors, since it provides a plethora of mineable data, which can be used for both detection and prognosis of prostate cancer. While current voxel-resolution radiomics-driven prostate tumor detection approaches utilize quantitative radiomics features associated with individual voxels on an independent basis, the incorporation of additional information regarding the spatial and radiomics feature relationships between voxels has significant potential for achieving a more reliable detection performance. Motivated by this, we present a novel approach for automatic prostate cancer detection using a radiomics-driven conditional random field (RD-CRF) framework. In addition to the high-throughput extraction and utilization of a comprehensive set of voxel-level quantitative radiomics features, the proposed RD-CRF framework leverages inter-voxel spatial and radiomics feature relationships to ensure that the autodetected tumor candidates exhibit interconnected tissue characteristics reflective of cancerous tumors. We evaluated the performance of the proposed framework using clinical prostate MP-MRI data of 20 patients, and the results of RD-CRF framework demonstrated a clear improvement with respect to the state-of-the-art in quantitative radiomics for automatic voxel-resolution prostate cancer detection.
I. INTRODUCTION
Prostate cancer is the most commonly diagnosed cancer in Canadian men (excluding non-melanoma skin cancers), with an estimated 24,000 new cases and 4,100 related deaths in 2015 [1] . According to the Canadian Cancer Society, prostate cancer is the third leading cause of death from cancer, accounting for 10% of cancer deaths in Canadian men. Despite these statistics, the prognosis for prostate cancer is relatively good if it is detected sufficiently early. Fast and reliable screening methods for prostate cancer are therefore crucial.
The current clinical method uses a digital rectal exam (DRE) or a prostate-specific antigen (PSA) test for initial screening. Men with a positive DRE or elevated PSA require a follow-up transrectal ultrasound (TRUS) guided biopsy to assess malignancy. The PSA test in particular has recently come under scrutiny. Recent studies [2] , [3] indicate that the PSA test has a high risk of overdiagnosis, with an estimated 50% of screened men being diagnosed with prostate cancer. This oversensitivity results in expensive and painful prostate biopsies, which cause discomfort, possible sexual dysfunction, and may result in increased hospital admission rates due to infectious complications [4] . The challenge diagnosticians face is how to improve prostate cancer diagnosis by reducing the overdiagnosis caused by conventional screening methods while still maintaining a high level of sensitivity.
Imaging-based tumor detection methods such as magnetic resonance imaging (MRI) have become more commonly used, but require an experienced medical professional to extensively review the data and perform a diagnosis. Methods for computer-aided prostate cancer detection are developed to assist diagnosticians with the process and to increase the reliability of diagnosis among clinicians. The use of multiple MRI modalities or multi-parametric MRI (MP-MRI) allows for unique information and features to be extracted from each modality, and shows potential for improving prostate cancer localization accuracy [5] .
One notable challenge is the variability between diagnosticians (''inter-observer variability'') and the variability of a single diagnostician over multiple sittings (''intra-observer variability'') when evaluating features across different MRI modalities [6] - [8] . This leads to inconsistencies in interpreting MP-MRI for prostate cancer diagnosis. The European Society of Urogenital Radiology (ESUR) recently introduced PI-RADS, the Prostate Imaging -Reporting And Diagnosis System [9] . PI-RADS is a set of guidelines for interpreting multiple MR images, and aims to raise the consistency between diagnosticians through a common set of criteria. Despite PI-RADS and further development to standardize the interpretation of multi-parametric MR images [10] , there is still a level of subjectiveness that can lead to inconsistent diagnosis. The use of automatic computer-aided prostate cancer detection aims to allow for a consistent and accurate diagnosis across different diagnosticians.
More recently, a particularly promising and powerful approach to cancer detection that could have significant potential for prostate cancer detection is radiomics [11] - [16] , [39] which involves the high-throughput extraction and utilization of a large amount of quantitative features for characterizing tumor phenotypes. Radiomics facilitates for a high-dimensional mineable feature space that can be utilized for both detection and prognosis [11] . Studies on lung and head-and-neck cancer patients have confirmed the prognostic power of radiomics features when it comes to patient outcome prediction for personalized medicine [11] - [13] . However, the prognostic capability of radiomics features has only very recently been investigated for prostate cancer detection and the quantitative characterization of prostate tumor phenotype.
Current methods for radiomics-driven automatic computeraided prostate tumor detection typically use a supervised method trained on a set of low-level features calculated from multi-parametric MR images.. Lemaître et al. [17] recently published a comprehensive review of state-of-the-art methods for prostate cancer detection and diagnosis. These radiomics-driven methods use hand-crafted feature sets and some combination of the following classifiers: Bayesian, random forest, logistic regression, neural network, linear discriminant, GentleBoost, support vector machines, relevance vector machines, fuzzy Markov random fields, and conditional random fields.
Madabhushi et al. [18] extracted three-dimensional texture features from MRIs that had been corrected for background inhomogeneity and nonstandardness. For each image voxel, a trained Bayesian classifier assigns a malignancy ''likelihood'' to each feature independently, and the ''likelihood'' images are then combined using an optimally weighted feature combination scheme. Using similar features as [18] , Tiwari et al. proposed a method that combines structural and metabolic imaging data for prostate cancer detection and detected cancerous regions within prostate tissue using a random forest classifier.
Duda et al. [19] published a semi-automatic multi-image texture analysis method that simultaneously analyzed several images (each acquired under different conditions) of the same organ. In addition to the features used by [18] , Duda et al. also extracted fractal-based and run length features and assessed the potential of multi-image texture analysis using different classifiers including logistic regression, a neural network, and support vector machines.
Litjens et al. [20] used features that represent pharmacokinetic behaviour, symmetry and appearance, and other anatomical aspects. In a two-stage computer-aided prostate cancer detection system, Litjens et al. detected initial candidates via multi-atlas-based prostate segmentation using a selective and iterative method for performance level estimation (SIMPLE) [21] . The authors then experimented with three different classifiers for voxel classification and candidate classification: linear discriminant, GentleBoost, and random forest.
Similar to Litjens et al., Vos et al. [22] also developed a two-stage classification approach for computeraided prostate cancer detection. Vos et al. analyzed lesion candidates and discriminated prostate cancer from benign abnormalities using a linear discriminant classifier. Ozer et al. [23] used parametric images derived from DCE (Dynamic Contrast-Enhanced) MRI, and proposed the use of relevance vector machines (RVM) with a Bayesian framework. Ozer et al. then evaluated the method against support vector machines (SVM) with the same framework.
Recently, the use of random fields for prostate cancer detection has grown in popularity. The use of fuzzy Markov random fields (MRFs) in particular has been investigated [24] - [26] , as fuzzy MRFs are an unsupervised method for cancerous tissue classification. Liu et al. [24] proposed a new method for estimating the parameters of the Markovian distribution of the measured data, and applied it to feature vectors extracted from multi-spectral prostate MRI datasets for prostate cancer detection. An extension on previous work, Ozer et al. [25] also propose the use of fuzzy MRFs as an unsupervised alternative to the previously proposed SVM and RVM, and evaluate the classifiers using feature vectors formed from the peripheral zone of multi-spectral prostate MRI datasets.
The Markov random fields (MRFs) [27] are a type of graphical models which incorporate the spatial relationship among random variables into a model as prior information. The MRF models encourage the neighbourhood relationship (pairwise potentials) among random variables to refine the state labels. Although the MRF models can improve the model accuracy by incorporating the spatial information, they ignore the relationship among states and measurements because of conditional independence assumption [28] . Tumor pixels are highly dependent on surrounding pixels because there is a strong interconnection among the tumor region pixels [26] . Therefore, the strong independence assumption is not accurate. In contrast to MRF models, conditional random fields (CRFs) [28] are graphical models which relax the conditional independence assumption by modeling the posterior probability of the state giving the measurement directly. They allow capturing dependencies between the measurements without relying on any model approximations [26] .
Lastly, Artan et al. [26] presented a cost-sensitive SVM cancer localization method as an extension to the conventional SVM for prostate cancer detection. Trained via a full grid search over the ν and γ values (SVM kernel parameters) to determine the optimal parameters, the cost-sensitive SVM shows improved results relative to the conventional SVM. Artan et al. also proposed a new segmentation method by combining conditional random fields (CRF) with a cost-sensitive framework. Using node potential parameters w obtained from SVM and subsequently estimated edge potential parameters κ, the cost-sensitive CRF demonstrated improved cost-sensitive SVM results by incorporating spatial information.
Inspired by genetic profiling for cancer risk stratification (genomics), Khalvati et al. [15] extended the T2-and apparent diffusion coefficient-based features from Peng et al. [16] and recently proposed comprehensive and quantitative radiomics feature models consisting of hundreds of radiomics features derived from MP-MRI data via feature selection and classification for the purpose of voxel-resolution prostate tumor detection. The results of this work demonstrated the detection power of radiomics for the purpose of automatic voxel-resolution prostate cancer detection. Nevertheless, one limitation of such voxel-resolution radiomics-driven prostate tumor detection approaches is that they utilize the extracted quantitative radiomics features associated with individual voxels on an independent basis, and do not account for the interconnected tissue characteristics reflective of cancerous tumors. As such, the incorporation of additional information regarding the spatial and radiomics feature relationships between voxels has significant potential for achieving a more reliable voxel-resolution radiomics-driven prostate cancer detection performance.
In this paper, we propose a novel approach for automatic prostate cancer detection based on a radiomics-driven conditional random field (RD-CRF) framework. The proposed RD-CRF framework utilizes the quantitative MP-MRI radiomics feature model proposed in [15] and incorporates not only the spatial relationships between voxels, but the quantitative radiomics feature relationships between voxels into a conditional random field model. This facilitates for the enforcement of interconnected tissue characteristics reflective of cancerous tumors, thus better representing the actual cancerous tissue phenotype. The paper is organized as follows. The methodology and underlying principles of the RD-CRF framework are described in Section II. Experimental setup and results are presented in Section III and discussions are presented in Section IV. Lastly, conclusions are drawn and future work is discussed in Section V.
II. METHODS
Here, we present the methodology and underlying principles of a novel method for automatic pixel-resolution prostate cancer detection via a radiomics-driven conditional random field (RD-CRF) framework. The proposed RD-CRF framework leverages the full set of pixel-level quantitative radiomics features and incorporates inter-pixel spatial and feature relationships via a conditional random field to detect tumors more reliably by taking into account the inter-connected tissue characteristics reflective of cancerous tumors. An overview of the proposed framework for pixelresolution prostate cancer detection is shown in Figure 1 . First, a large amount of quantitative radiomics features are extracted from MP-MRI data using a quantitative radiomics feature model. Second, a classifier trained using such quantitative radiomics features from training data is used to perform initial pixel-resolution cancer detection. A radiomics-driven conditional random field (RD-CRF) framework is then used to perform final pixel-resolution cancer detection using the initial results produced by the classifier and the full set of extracted quantitative radiomics features of the current patient case. The detailed methodology behind each step of the proposed framework is described below.
A. QUANTITATIVE RADIOMICS FEATURE MODEL
The proposed framework incorporates the quantitative radiomics feature model proposed in [15] , which was specifically designed for extracting a large number of quantitative radiomics features from MP-MRI data for the purpose of prostate cancer detection. Sets of 96 low-level radiomics features (4 from first-order and 72 from second-order statistical features, 8 from Kirsch edge detection, and 12 from Gabor filters [15] ) were extracted from each of following 8 different forms of MP-MRI data: i) T2-weighted (T2w) imaging data, ii) apparent diffusion coefficient (ADC) data, iii) computed high-b diffusion-weighted imaging (CHB-DWI) data, iv) correlated diffusion imaging (CDI) data, and v-viii) diffusion-weighted imaging (DWI) data acquired at 4 individual b-values (0, 100, 400, and 1000s/mm 2 ). This results in a total of 768 features used within the comprehensive quantitative radiomics feature model that can better capture both healthy and cancerous tissue characteristics. A SVM classifier was then trained using quantitative radiomics features extracted from training data using this radiomics feature model, which can then be used to perform voxel-resolution classification on a new unseen patient case.
The MP-MRI modalities used in this radiomics feature model were selected based on their potential to separate cancerous from healthy prostate tissue. T2w imaging data VOLUME 3, 2015 FIGURE 1. The proposed framework for automatic voxel-resolution prostate cancer detection. A large amount of quantitative radiomics features are extracted from MP-MRI data using a quantitative radiomics feature model. A classifier trained using quantitative radiomics features from training data is used to perform initial voxel-resolution cancer detection. A radiomics-driven conditional random field (RD-CRF) framework is then used to perform final voxel-resolution cancer detection using the initial results produced by the classifier and the full set of extracted quantitative radiomics features of the current patient case.
has been shown to provide some localization information for tumor candidates due to a small reduction in signal in the cancerous tissue [5] . Similarly, cancerous tissue in ADC data is typically represented by a darker intensity relative to surrounding tissue [29] . Previous research has shown that high-b values in diffusion weighted imaging data allows for increased delineation between cancerous and healthy tissue [30] , [31] . Lastly, CDI data takes advantage of joint correlation in signal attenuation across multiple gradient pulse strengths and timings to improve delineation between cancerous and healthy tissue [32] , [33] . One challenge with classifying tissues into cancerous and healthy as performed in existing state-of-the-art voxel-resolution radiomics-driven cancer detection methods (e.g., [15] ) is that the detected tumor candidates tend to be sparsely distributed across the prostate region (see Figure 2 ), leading to high false positive and negative rates. This sparsity is a result of existing approaches not taking into account inter-voxel spatial relationships and radiomics feature relationships between voxels, and results in situations where there are missing voxels within a tumor candidate, as well as scattered voxels that may be considered as cancerous voxels. As cancerous tissue tends to be localized to one or two regions of a prostate, and exhibit interconnected tissue characteristics, this motivates the use of a probabilistic radiomics-driven framework that better accounts for such characteristics to improve prostate cancer detection performance, which will be described in the next section. Therefore, the proposed framework incorporates cross-modality spatial priors to enforce spatial relationships between voxels while maintaining relationships between cross-modality radiomic features.
B. RADIOMICS-DRIVEN CONDITIONAL RANDOM FIELD FRAMEWORK
The theory behind the radiomics-driven conditional random field (RD-CRF) framework used to perform final voxelresolution cancer detection based on the initial results produced by the classifier and the full set of extracted quantitative radiomics features of the current patient case can be described as follows. Conditional random fields were first proposed by Lafferty et al. [34] and have previously been used for image labelling [35] . Although the voxel-level quantitative features derived from MP-MRI data extracts informative features which can discriminate the voxels to healthy and tumor classes, they do not incorporate the relationships among neighbourhood voxels into the model. The neighbourhood voxels usually have the same characteristics leading to the same class label; therefore, using spatial information can improve the model accuracy if there is a misclassification based on the voxel-level features. Markov random fields (MRFs) and conditional random fields (CRFs) are two main approaches to incorporate the spatial information in the modeling. Although both frameworks can handle spatial information, researches have shown that CRFs have better performance compared to MRF models [27] . The CRF models formulate the spatial information by utilizing the measurement and states simultaneously while the MRF models incorporate the spatial information in the state estimation without considering the measurement.
The proposed RD-CRF model extends the conditional random field (CRF) model to leverage the full set of voxel-level quantitative radiomics features derived from MP-MRI data while taking into account the spatial relationships and quantitative radiomics feature relationships between voxels to better enforce interconnected tissue characteristics. Given the prostate MP-MRI data pertaining to the patient, the tumor detection problem is formulated as the conditional probability of a set of binary labels (i.e., suspected prostate tumor or healthy tissue). The RD-CRF framework models the conditional probability of the binary label field Y and corresponding X observations as follows:
where Z (X ) is the normalizing function and E(Y , X ) represents the energy function factorized from different feature functions. The labelling problem of the prostate as healthy or cancerous is optimized using a Maximum A Posteriori (MAP) approach where minimizing the energy function E(Y , X ) produces the best classification of healthy tissue and tumor candidates:
where Y * is the optimal solution given the patient's MP-MRI. As Y * maximizes the probability of healthy and cancerous tissue classification via the minimization of E(Y , X ), the formulation of the energy function is crucial in obtaining an accurate binary label field. E(Y , X ) can be formulated as some combination of unary and pairwise potential functions, and is generally defined as:
E(Y , X ) incorporates the data-driven unary function ψ u (y i , X ) and the inter-voxel spatial and radiomics features-based pairwise function ψ p (y ϕ , X ) into the model. In Equation 3 ,
and represents the label of a single voxel in the binary label field. X = {x i } n i=1 is the corresponding set of observations from the prostate MR-MRI data as represented by the quantitative radiomics features, and y ϕ ∈ Y is the subset of states (clique) in the surrounding neighbourhood. For each node i, there is a set of neighbours N (i) for a neighbourhood size
The neighbourhood size |N (i)| was empirically determined to be m = 24, corresponding to a 5 × 5 neighbourhood centred at node i. The proposed RD-CRF framework uses a pairwise clique structure
(5)
to enforce the consistency of spatial and radiomics feature relationships in the identification of tumor candidates. Each node i represents a single voxel in a patient's MP-MRI data, and N (i) represents the corresponding neighbouring axial voxels. For the proposed RD-CRF framework, the results of the trained classifier are used as the data-driven unary term ψ u (.), while the pairwise term ψ p (.) is factorized based on the set of clique structures C for a pairwise clique c ∈ C.
By taking full advantage of the comprehensive set of 768 quantitative radiomics features extracted from the different MP-MRI modalities along with spatial and radiomics feature relationships within the RD-CRF framework, one can better characterize healthy and cancerous tissue phenotype and thus achieve improved final voxel-resolution cancer detection.
To obtain the final voxel-resolution tumor detection results, the energy function E(Y , X ) is minimized using gradient descent, and the binary label field is assigned to each voxel as y * ∈ optimal solution Y * (as defined in Equation 2):
Graph G(V , E) is the realization of the proposed RD-CRF for an axial MRI slice, where V is the set of nodes representing the states Y * = {0, 1} and E is the set of edges of the graph.
As shown in Figure 3 , each node y represents a single voxel and has a set of associated observations x i . Each x i represents the set of quantitative radiomics features [15] calculated across all MP-MRI modalities for a given voxel. The edge e ij is the connectivity between a pair of nodes, and represents the relationship between two voxels. 
III. RESULTS

A. IMAGE DATA
The performance of the proposed framework was evaluated using the MP-MRI data of 20 patients (17 with cancer and 3 without cancer) acquired using a Philips Achieva 3.0T machine at Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. Institutional research ethics board approval for this study was obtained at Sunnybrook Health Sciences Centre. For each patient, the following MP-MRI modalities were obtained (Table 1) : i) T2w, ii) DWI, and iii) CDI. To ensure voxel-level correspondence between T2w, DWI, and CDI image, the T2w images were down-sized to match the voxels size of DWI and CDI images. The patients' age ranged from 53 to 83. Table 1 summarizes the information about the 20 patients' datasets used in this research. MP-MRI imaging data were processed in the ProCanVAS (Prostate Cancer Visual Analysis System) platform developed jointly by Sunnybrook Research Institute, Toronto, ON, Canada and the University of Waterloo, Waterloo, ON, Canada. The data set includes segmentation information to isolate the prostate, and ground truth data for tumor size and location. All imaging data were reviewed and marked as healthy and cancerous tissue by a radiologist with 18 and 13 years of experience interpreting body and prostate MRI, respectively. For cases with cancer, the MP-MRI images and expert annotations were compared to the corresponding histopathology data, obtained through radical prostatectomy with Gleason score 7 and above, as ground truth to confirm the accuracy of the MP-MRI markings. There was a total of 67 tumors across the patient slices, and the sizes for the 25, 50, and 75 percentiles were 21.90mm 2 , 58.41mm 2 , and 136.28mm 2 , respectively.
B. EXPERIMENTAL SETUP
The experimental setup used to assess the efficacy of the proposed RD-CRF framework for voxel-resolution prostate cancer detection is described as follows. Each patient dataset had corresponding T2w imaging data, ADC data, CHB-DWI data, and CDI data. For each modality, the testing data contained a total of 40,975 samples (40,369 healthy and 606 cancerous samples confirmed by the radiologist) across the slices from 20 different patients. 1 Using the radiologist contour of the prostate, a rectangle cropped around the prostate gland was selected as the region of interest (ROI) for each MP-MRI slice. The voxel-resolution cancer detection results produced by the proposed RD-CRF framework was compared with that produced using the state-of-the-art method proposed in [15] via sensitivity, specificity, and 1 To balance the training data in terms of number of healthy and cancerous samples, when training the SVM classifier, smaller subsets of healthy samples are randomly selected to be the same size as the cancerous samples and this is repeated 50 times and the classification results are averaged. This way, the training data used for training SVM classifier becomes 50% − 50% leveled with respect to cancerous and healthy samples [15] . accuracy metrics. Sensitivity = TP P Specificity = TN N Accuracy = TN + TP N + P where the performance of each method was quantified by the metrics' closeness to one. TP is the number of voxels in the intersection of the method's identified cancerous tissue and the voxels contained in the radiologist's tissue markings, TN is the number of voxels not in the method's identified tissue that are also not in the radiologist's markings, N is the number of voxels not in the radiologist's marked tissue, and P is the number of voxels in the radiologist's marked tissue.
In addition, the Jaccard index and Sørensen-Dice coefficient were used to compute the overlap between the radiologist's marked tissue and the voxel-resolution cancer detection results produced by the proposed RD-CRF framework and the state-of-the-art method proposed in [15] .
|A| + |B| where A is the set of voxels contained in the method's identified cancerous tissue and B is the set of voxels contained in the radiologist's tissue markings. The performance of each method was evaluated using leave-one-patient-out cross-validation, with training radiomics features were selected from all but one patient and used to train the classifier, and the voxels in the remaining patient's MRI dataset were classified as either healthy and cancerous tissue. Table 2 shows the average sensitivity, specificity, accuracy, Jaccard index, and Sørensen-Dice coefficient for the proposed RD-CRF, Khalvati et al. [15] , and Peng et al. [16] across all patients. The proposed RD-CRF method shows significant improvement via p-value testing 2 (p-values < 0.05) for all metrics compared to radiomics alone approaches [15] , [16] . [15] , and [16] performance metrics along with statistical significance (p-values < 0.05) between RD-CRF and [15] . Table 3 shows the improvement of the proposed RD-CRF framework with respect to [15] for different cases starting with 5 worst cases for sensitivity obtained by [15] . As it can be seen from Table 3 , for the first 5 worst cases, the proposed RD-CRF framework improved sensitivity by 3.2%. When all 20 cases were taken into account, the proposed RD-CRF framework improved sensitivity, specificity, and TABLE 3. RD-CRF performance improvement with respect to [15] for different numbers of cases selected based on an ascending order for sensitivity, starting with the worst case.
C. QUANTITATIVE RESULTS
accuracy by 1.10%, 0.55%, and 0.59%, respectively. Given that [15] already achieved high specificity rates (e.g., 91%), the proposed RD-CRF framework was only able to improve it slightly (0.55%). FIGURE 4. RD-CRF performance improvement in sensitivity and specificity compared to [15] for different numbers of cases selected based on an ascending order for sensitivity, starting with the worst case. FIGURE 5. RD-CRF sensitivity (shown in blue) compared to [15] (shown in red) for different numbers of cases selected based on an ascending order for sensitivity, starting with the worst case. Figure 4 shows the improvement in sensitivity and specificity obtained by the proposed RD-CRF framework when compared to [15] . Figures 5 and 6 show the actual sensitivity and specificity numbers for [15] and the proposed RD-CRF framework with respect to number of cases, starting with the worst cases in term of sensitivity. It is seen that although the first 5 worst cases exhibit the highest gain in sensitivity (i.e., 3.2%), the performance improvement is FIGURE 6. RD-CRF specificity (shown in blue) compared to [15] (shown in red) for different numbers of cases selected based on an ascending order for sensitivity, starting with the worst case.
maintained across different number of cases (e.g., 1.1% for sensitivity for 20 cases).
The proposed RD-CRF framework increased the sensitivity, specificity, and accuracy of [15] , indicating that taking into account inter-voxel spatial and radiomics feature relationships helps in mitigating the identification of sparsely distributed tumor candidates and improving prostate cancer detection performance. Figure 7 shows examples of how the proposed RD-CRF framework mitigates sparsely distributed tumor candidates while promoting consistency in spatial and radiomics feature relationships to ensure the identified tumor candidates better reflect cancerous tumors. Figure 7 shows the prostate tumor candidates detected using [15] , [16] , and that detected using the proposed RD-CRF framework in comparison to the radiologist's markings. Figure 8 shows sample results for [15] , [16] , RD-CRF, and the radiologist's markings along with the corresponding pathology data. The pathology data indicates additional smaller tumors present in the prostate tissue. While [15] , [16] , and the proposed RD-CRF framework failed to detect these small areas of cancerous tissue, the radiologist's markings also did not identify these small tumors, which illustrates that such small areas of cancerous tissue may not exhibit significantly distinctive image-based features in the MP-MRI data, which suggests that more information via new imaging modalities is required.
IV. DISCUSSION
Computer-aided detection (CAD) algorithms for prostate cancer are mainly based on exploiting the imaging characteristics to train a classifier such as SVM, enabling it to classify new cases. Radiomics attempts to augment this approach by utilizing a large amount of quantitative imaging-based features to improve the classification results. The common theme in these radiomics-driven approaches is the fact that single voxels are studied individually and inter-voxel spatial and feature relationships are usually overlooked. In contrast, we have proposed a radiomics-driven conditional random field (RD-CRF) framework to incorporate the inter-voxel FIGURE 7. Visual comparison of identified prostate tumor candidates produced by [15] , [16] and the proposed RD-CRF framework. The proposed RD-CRF framework produced results that show a noticeable reduction in sparsely distributed tumor candidates and increased spatial consistency in detected tumor candidates. Left to right: radiologist's markings (green), results produced by [16] (yellow), results produced by [15] (red), results produced by RD-CRF (blue), and all results shown in one image.
relationships by jointly enforcing multi-parametric radiomics features consistency and spatial consistency with the pairwise term (Equation 3 ). This enforces the compactness and radiomics-based connectedness of the classification results, leading to the better representation of prostate tumors and a better separation of cancerous and healthy tissues.
The proposed RD-CRF framework can incorporate any given quantitative radiomics feature model that classifies image voxels for a given case such as prostate cancer. In prostate cancer, one of the challenges that the CAD algorithms face is the fact that the cancerous voxels are a small fraction of the prostate gland (i.e., less than 1%). This leads to poor sensitivity results in a significant number of cases. As previously stated, there is a wide range of tumor sizes, making a size-based criterion for the removal of false positives ineffective; rather, we incorporate radiomic information in the RD-CRF to better interpret size information and refine the classification results. To demonstrate the effectiveness of the proposed RD-CRF framework, we calculated the results starting with the worst sensitivity cases obtained by [15] . As it can be seen, the proposed RD-CRF framework was able to improve sensitivity by 3.2% for first 5 cases and 1.10% for all 20 cases while in all cases specificity was improved by 0.60%. The low gain in specificity is mainly due to high specificity rates obtained by [15] (e.g., 91%) making it difficult for the RD-CRF framework to further improve performance.
The proposed RD-CRF framework can improve CAD algorithms with respect to sensitivity enabling them to become reliable for cancer screening programs where high sensitivity rates are required. It should be noted that improving sensitivity slightly is important when it comes to real-world scenarios where a detection algorithm may be used for cancer screening. In this scenario, even a modest improvement in sensitivity can spare a patient from wrongly labelled as healthy. Furthermore, [15] also tends to identify more sparsely distributed tumor candidates leading to false positive cases (Figure 7 ). The proposed RD-CRF framework can also help improve specificity of CAD algorithms to be used in procedures such as radical prostactomy where a very high specificity is required to prevent unnecessary surgeries. As seen in Figure 7 , the proposed RD-CRF framework identified a single compact region (e.g., fifth row) and also extended the identified tumor candidate to an added region (e.g., second row).
As it is used to refine classification results, additional computation time is required for the RD-CRF framework to enforce inter-voxel information via the enforcement of radiomic features and spatial consistency. A preliminary run-time study was conducted, and the average computation time for the refinement of a prostate MRI slice was found to be approximately 0.15sec on the following desktop: Intel Core i7-3770 CPU 3.40GHz 3.40GHz, RAM: 24GB. For a very small computational cost, a notable improvement in the classification results is achieved.
While Table 3 indicates that the RD-CRF framework generally improved the classification results, RD-CRF is limited by the initial classification results from the trained classifier. Figure 9 shows examples of cases where the initial trained classifier failed to identify tumor candidates as cancerous, resulting in incorrect tumor candidate classifications when using the RD-CRF framework.
The example shown in the first and second row of Figure 9 are cases where the initial trained classifier [15] failed to identify tumor candidates entirely while the third row shows a case where the initial trained classifier partially identifies the tumor. While [16] was able to capture part or all of these tumors, the method also identifies most of the prostate as cancerous resulting in poor delineation of the tumor itself from the surrounding tissue. A visual inspection shows that the texture in the radiologist-marked regions appears similar to other healthy prostate tissue. This suggests that the MP-MRI modalities and corresponding extracted quantitative radiomics features do not capture all underlying texture characteristics of cancerous tissue, thus resulting in the radiomics feature model to not properly identify the suspicious regions. This suggests that more information (via new imaging modalities or the discovery of new quantitative radiomics features) is required to capture such cases.
In this paper, the proposed algorithms was validated using the markings of a clinician. As future work, a multiple reader study will be performed to determine the reproducibility and variability of the proposed algorithm, as well as comparing detected tumors directly against pathology data as ground truth. Moreover, leave-one-patient-out validation was used to generate the results which, as opposed to n-fold cross validation, does not yield confidence intervals for the results. This may limit the interpretation of the results in a meaningful way. In future work, we will use a larger dataset with n-fold cross validation to overcome this limitation.
Future work also includes incorporating additional MRI modalities, and extending the pairwise potential used to characterize spatial and radiomics feature relationships to better enforce spatial and feature consistency and improve detection performance. The radiomics feature model used here incorporated CDI as one of the imaging modalities which, as shown in [15] , boosts the initial results significantly. We have developed an enhanced version of CDI, called dual-stage correlated diffusion imaging (D-CDI), which has shown promise in enhancing separability of cancerous and healthy tissue in prostate MRI compared to CDI [33] . As future work, we will incorporate D-CDI into the radiomics feature model used by the RD-CRF framework to investigate its efficacy in improving prostate cancer detection performance.
The introduction of a hierarchical RD-CRF framework will also be investigated for the incorporation of morphological features and asymmetric characteristics of cancerous tissue in the prostate gland. We will investigate using a hybrid morphological-textural feature model as an initial classifier for the RD-CRF framework where in addition to texture analysis, the morphological characteristics (e.g., shape) of candidate regions are taken into account to detect cancer [36] . In addition, currently, the RD-CRF framework operates in 2D where the spatial consistencies are taken into account in individual slices. As future work, we will extend the framework to 3D to also account for region compactness across 3D slices.
Furthermore, the DWI data captured at different b-values are usually distorted due to patient movement during the image acquisition, and thus may reduce cancer separability and affect the cancer detection performance of the RD-CRF framework. We have presented preliminary results for co-registering the b-value images to compensate for patient movement [37] which we will incorporate into our proposed RD-CRF framework to investigate the effect on the accuracy of cancer detection. Finally, we will use tumor region candidates defined by statistical textural distinctiveness [38] as the initial regions used for classification and enforcing spatial consistency and radiomics feature relationships by RD-CRF.
V. CONCLUSION
A novel framework was proposed for automatic prostate cancer detection using multi-parametric magnetic resonance imaging via a radiomics-driven conditional random field (RD-CRF) framework. Experimental results showed that the proposed RD-CRF framework improved the sensitivity, specificity, and accuracy compared to a stateof-the-art voxel-resolution radiomics-driven prostate cancer detection method. While the overall effectiveness of the RD-CRF framework is limited by the initial classification results, the RD-CRF framework was shown to improve the detection of tumor candidates by mitigating sparsely distributed tumor candidates and improving the detected tumor candidates via spatial consistency and radiomics feature relationships. Thus, the RD-CRF framework shows potential for more efficient and accurate computer-aided prostate cancer diagnosis for clinicians.
